Wednesday, February 05, 2020

Biogen wins in Tecfidera patent case; share price goes up.

From Barron's on Wednesday, 5 Feb. 2020 :

Shares of the biotech firm Biogen jumped more than 23% midday Wednesday [Feb. 5]
after the company won a long-awaited decision in a patent case defending its
multiple sclerosis drug Tecfidera against a challenge by Mylan.


IPR2018-01403 on US 8,399,514

See also: : Biogen's Multiple Sclerosis Drug, Tecfidera, Faces Another IPR Threat


Post a Comment

<< Home